Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-05

FDA Approved: ERLOTINIB — Original Application (Armas Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Armas Pharmaceuticals' original application (ANDA211960) for erlotinib hydrochloride as a generic version of erlotinib, for the treatment of no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erlotinib hydrochloride (Erlotinib)

Snippet

ORIG AP for ERLOTINIB (ERLOTINIB HYDROCHLORIDE)